Pluto Bioinformatics

GSE130246: RNA-seq control (sgNT) and TLE3KO (sgTLE3) cells treated with 10 uM enzalutamide or vehicle

Bulk RNA sequencing

To investigate the transcriptional consequences of TLE3 loss in the presence/absence of AR inhibitor enzalutamide in prostate cancer cells, the transcriptomes of WT and TLE3KO cells treated with vehicle or enzalutamide (10 uM) were compared. . SOURCE: Sander Palit (s.palit@nki.nl) - Netherlands Cancer Institute